Back to AI Catalogue
VUNO Med®-DeepBrain®

VUNO Med®-DeepBrain®

Developed byVUNO Inc.

What is VUNO Med®-DeepBrain®?

VUNO Med®-DeepBrain® is a highly accurate, fast atrophy and WMH measurement AI solution to assist diagnosis of neurodegenerative diseases.

Request demo

About the Algorithm

DETAILS
VUNO Med®-DeepBrain® by Vuno Inc.: AI-based medical device for quantitative analysis of the brain

VUNO Med®-DeepBrain® aids in neurodegenerative disease diagnosis by detecting cerebral small vessel disease and quantifying brain atrophy using MRI.

The software assists in the diagnosis of neurodegenerative diseases such as Alzheimer’s disease based on normative percentile score and volume information for a hundred brain areas.

The benefits

  • Instant neuroradiologist co-pilot
  • Analyze a brain MRI image within 1 minute, reducing time to diagnosis
  • Increase reliability of volume measurement & diagnostic precision by providing quantitative data
  • Easy to integrate with current workflow
  • Preset with intuitive reports & color-coded overlays

Key features

  • Brain segmentation in 100+ areas
  • Immediate quantification of brain volume, atrophy & cortical thickness
  • Provide segmented brain region percentiles compared to age/gender matched normal
  • Follow DICOM standard format allowing PACS integration
  • Ability to select necessary information for a variety of reports
  • Clinically proven (3,000+ training cases)

Application Area

Diagnosis of neurodegenerative disorders

Suggested use

VUNO Med®-DeepBrain® is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures and lesions

Data characteristics

VUNO Med®-DeepBrain® provides brain structural information based on the brain MR image. Input images for analysis are 3D T1 weighted brain MR images and 2D T2 flair brain MR images. Once the recommended images are uploaded, automated brain segmentation is performed and provides volumetric data of brain regions. It is displayed in the viewer with a color map.

Certifications

CE, MFDS and FDA approved.

Development and validation of a deep learning-based automatic segmentation model for assessing intracranial volume: comparison with NeuroQuant, FreeSurfer, and SynthSeg Impact of white matter hyperintensity volumes estimated by automated methods using deep learning on stroke outcomes in small vessel occlusion stroke Deep learning-based, fully automated, pediatric brain segmentation

I have been using VUNO Med®-DeepBrain® in my clinical practice and research for the past three years. It provides objective information not detectable through visual assessment alone, such as subtle atrophic changes in the hippocampus and asymmetric volume changes in the cerebral hemispheres in patients with dementia or seizures. It not only enhances clinical diagnosis but also facilitates research by providing valuable insights into brain volume variations and development. VUNO Med®-DeepBrain® has become an indispensable tool in my practice and research, offering information comparable to a new MRI sequence.

I have been using VUNO Med®-DeepBrain® in my clinical practice and research for the past three years. It provides objective information not detectable through visual assessment alone, such as subtle atrophic changes in the hippocampus and asymmetric volume changes in the cerebral hemispheres in patients with dementia or seizures. It not only enhances clinical diagnosis but also facilitates research by providing valuable insights into brain volume variations and development. VUNO Med®-DeepBrain® has become an indispensable tool in my practice and research, offering information comparable to a new MRI sequence.

Eunhee Kim, M.D. Clinical Professor, Division of Neuroradiology, Department of Radiology, Ewha Womans University Mokdong Hospital, Seoul, South Korea
OUR PARTNERS

Developed by

  • linkedian

VUNO Inc. was founded when the global AI-based medical industry was at an embryonic stage. VUNO are on a mission to “View the Invisible, Know the Unknown”, and aim to realize the infinite possibilities of AI technology in the field of medicine. As a pioneer in the Medical AI industry, VUNO will continue to develop and explore the possibilities of medical AI to leverage a wide range of data including medical imaging, pathology, bio-signals, speech recognition, and more.

Vuno Inc
RECOMMENDED

Similar Algorithms

algoritham_bg
Neuroradiology

qER

by Qure.AI

qER is an AI-powered solution for timely care of stroke & TBI. The solution has

Discover this algorithm
algoritham_bg
Neuroradiology

BrainScan CT

by BrainScan.AI

BrainScan CT is an AI-powered software solution designed for CT scan analysis an

Discover this algorithm

Would you like to try VUNO Med-DeepBrain?

Let’s collaborate to harness the transformative power of these advanced technologies, propelling your medical practice to unprecedented levels of diagnostic accuracy, efficiency, and patient care.

Redeem your demo!
×